New genera of flavonols and flavonol derivatives as therapeutic molecules
Journal of the Korean Society for Applied Biological Chemistry volume 54, pages 1–18 (2011)
Natural products from plants and microorganisms traditionally have provided the pharmaceutical industry with one of the most important sources of “lead” compounds in the search for new drugs and medicines. The diversity of polyphenol structure is enormous. They are classified into several classes, the most important polyphenol in our food being phenolic acids and flavonoids, which include flavonol as one of subgroups. Flavonols are a group of plant secondary metabolites containing hydroxyl in 3rd position of chromone ring of a ‘6+3’ flavonoid ring structure. Several health beneficial activities have been attributed to these naturally occurring plant flavonols, including antioxidative, anticarcinogenic, vasoprotective, anti-inflammatory, neurodegenerative, antidiabetic, antiplatelet activities, among which antioxidative properties remain the main topic investigated in recent years. The main aim of this review is to put forward the pharmacological importance of major flavonols and newly found flavonol derivatives from the last 10 years and their related bioactivity as lead compounds. The bioactivity of these flavonoids depends on structure-activity relationship (SARs), the flavonols being one of the structurally active compounds. Most studies have demonstrated their occurrence and their absorption in humans, but the question remains as to which form is actually absorbed: aglycone, glycosidic or both. The major flavonols such as quercetin, kaempferol, myricetin, rutin, isorhamnetin, and galangin were found to exhibit anticancer activity. These flavonols also have positive effects on major diseases such as cardiovascular disease, type-2 diabetes, and Alzheimer’s disease. They are also found to have therapeutic value against osteoporosis, platelet aggregation, and antioxidant activity, the major action of prevention.
Ahn J, Lee H, Kim S, Park J, and Ha T (2008) The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun 373, 545–549.
Ahrene SA and O’Brien NM (2002) Dietary Flavonols: Chemistry, food content, and metabolism. Nutr 18, 75–81.
Ajay M, Gilani AH, and Mustafa MR (2003) Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci 74, 603–612.
Akhlaghi M and Bandy B (2009) Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 46, 309–317.
Avila MA, Velasco JA, Cansado J, and Notario V (1994) Quercetin mediates the down regulation of mutant P53 in the human breast cancer cell line MDA MB468. Cancer Res 54, 2424–2428.
Aziz AA, Edwards CA, Lean MEJ, and Crozier A (1998) Absorption and excretion of conjugated flavonols, including quercetin-4′-o-β-glucoside and isorhamnetin-4′-o-β-glucoside by human volunteers after the consumption of onions. Free Radic Res 29, 257–269.
Bao Y, Williamson G, De Pascual-Teresa S, O’Leary KA, Needs P, and O’Brien N (2004) Effect of flavonoids and Vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutation Res 551, 245–254.
Bestwick CS and Milne L (2006) Influence of galangin on HL-60 cell proliferation and survival. Cancer Lett 243, 80–89.
Boots AW, Haenen GR, and Bast A (2008) Health effects of quercetin: From antioxidant tonutraceutical. Eur J Pharmacol 585, 325–337.
Bruneton J (1999) Pharmacognosie-Phytochimie-Plantes Me’dicinales, (3rd ed.), p.310, Tec & Doc, Paris, France.
Butterfield DA, Castegna A, Pocernich CB, Drake J, Scapagnini G, and Calabrese V (2002) Nutritional approaches to combat oxidative stress in Alzheimer’s disease. J Nutr Biochem 13, 444–461.
Capasso R and Mascolo N (2003) Inhibitory effect of the plant flavonoid galangin on rat vas deferens in vitro. Life Sci 72, 2993–3001.
Casagrande R, Georgetti SR, Verri WA JR, Borin MF, Lopez RFV, and Fonseca MJV (2007) In vitro evaluation of quercetin cutaneous absorption from topical formulations and its functional stability by antioxidant activity. INT J PHARM 328, 183–190.
Chang TK, Chen J, and Yeung EY (2006) Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: Identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1. Toxicol Appl Pharmacol 213, 18–26.
Chen H and Zuo Y (2007) Identification of flavonol glycosides in American cranberry fruit. Food Chem 101, 1357–1364.
Chen Y and Deuster P (2009) Comparison of quercetin and dihydroquercetin: Antioxidant independent actions on erythrocyte and platelet membrane. Chem-Biol Interactions 182, 7–12.
Crozier A, Lean MEJ, McDonald MS, and Black C (1997) Quantitative analysis of the flavonoids content of commercial tomatoes, onions, lettuce and celery. J Agric Food Chem 45, 590–595.
Dai F, Miao Q, Zhou B, Yang L, and Liu ZL (2006) Protective effects of flavonols and their glycosides against free radical-induced oxidative hemolysis of red blood cells. Life Sci 78, 2488–2493.
Day AJ, Bao Y, Morgan MRA, and Williamson G (2000b) Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 29, 1234–1243.
Day AJ, Cañada FJ, Diaz JC, Kroon PA, Mclauchlan R, Faulds CB, Plumb GW, Morgan MRA, and Williamson G (2000a) Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 468, 166–170.
Deschner EE, Ruperto J, Wong G, and Newmark HL (1991) Quercetin and rutin as inhibitors of azoxymethanol induced colonic neoplasia. Carcinogenesis 12, 1193–1196.
De Souza KCB, Bassani VL, and Schapoval EES (2007) Influence of excipients and technological process on anti-inflammatory activity of quercetin and Achyrocline satureioides (Lam.) D.C. extracts by oral route. Phytomed 14, 102–108.
de Vrie JHM, Karin Janssena PLTM, Hollman PCH, van Staverena WA, and Katan MB (1997) Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. Cancer Letters 114, 141–144.
Dugas AJ JR, Castaneda-Acosta J, Bonin GC, Price KL, Fischer NH, and Winston GW (2000) Evaluation of the total peroxyl radical-scavenging capacity of flavonoids: structure-activity relationships. J Natl Prod 63, 327–331.
Duthie GG, Duthie SJ, and Kyle JAM (2000) Plant polyphenols in cancer and heart disease: implications as nutritional antioxidants. Nutr Res Rev 13, 79–106.
Elisabetta C, Nadia R, Fabrizio C, and Roberto T (1995) Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes. Life Sci 57, 1741–1751.
Fang SH, Hou YC, and Chao PD (2005) Pharmacokinetic and pharmacodynamic interactions of morin and cyclosporin. Toxicol Appl Pharmacol 205, 65–70.
Fang Z, Zhang M, and Wang L (2007) HPLC-DAD-ESIMS analysis of phenolic compounds in bayberries (Myrica rubra Sieb. et Zucc.). Food Chem 100, 845–852.
Fossen T, Pederson AT, and Anderson OM (1998) Flavonoids from red onion (Allium cepa). Phytochem 47, 281–285.
Giulia DC, Nicola M, Angelo AI, and Francesco C (1999) Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci 65, 337–353.
Gliszyńska-Świgło A, van der Woude H, de Haan L, Tyrakowsk B, Aarts JMMJG, and Rietjens IMCM (2003) The role of quinone reductase (NQO1) and quinone chemistry in quercetin cytotoxicity. Toxicol in Vitro 17, 423–431.
Graf BA, Milbury PE, and Blumberg JB (2005) Flavonols, Flavones, Flavanones, and Human Health: Epidemiological Evidence. J Med Food 8, 281–290.
Griffiths LA (1982) Mammalian metabolism of flavonoids. In The Flavonoids: Advances In Research, Harborne JH and Mabry TJ (eds.), p. 68. Chapman and Hall, London, UK.
Grundy SM (2007) Metabolic syndrome: A multiplex cardiovascular risk factor. J Clin Endocrinol Met 92, 399–404.
Gurib-Fakim A (2006) Medicinal Plants: Traditions of yesterday and drugs of tomorrow. Mol Asp Med 27, 1–93.
Hackett AM (1986) The metabolism of flavonoid compounds in mammals. In Plant Flavonoids In Biology And Medicine: Biochemical, Pharmacological, And Structure-activity Relationships, Cody V, Middleton E, and Harborne JB (eds.), pp.177–194, John Wiley & Sons, New York, NY, USA.
Harborne JB (1986) Nature, distribution, and function of plant flavonoids. In Plant Flavonoids In Biology And Medicine: Biochemical, Pharmacological, And Structure-activity Relationships, Cody V, Middleton E, and Harborne JB (eds.), pp. 15–24, John Wiley & Sons, New York, NY, USA.
Harborne JB and Mabry TJ (1988) In The Flavonoids: Advances In Research, pp. 1–16, Chapman and Hall, London, UK.
Heller W (1986) Flavonoid biosynthesis: an overview. In Plant Flavonoids In Biology And Medicine: Biochemical, Pharmacological, And Structure-activity Relationships, Cody V, Middleton E, and Harborne JB (eds.), pp. 25–42, John Wiley & Sons, New York, NY, USA.
Heo MY, Sohn SJ, and Au WW (2001) Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. Mutation Res 488, 135–150.
Hernández V, Recio MC, Màñez S, Giner RM, and Rios JL (2007) Effects of naturally occurring dihydroflavonols from Inula viscosa on inflammation and enzymes involved in the arachidonic acid metabolism. Life Sci 81, 480–488.
Higa S, Hirano T, Kotani M, Matsumoto M, Fujita A, Suemura M, Kawase I, and Tanaka T (2003) Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils. J Aller Clin Immun 111, 1299–1306.
Hollman PCH (2000) Evidence for health benefits of plant phenols: Local or systemic effects? J Sci Food Agric 81, 842–852.
Hollman PCH, Bijsman MNCP, van Gameren Y, Cnossen EPJ, de Vries JHM, and Katan MB (1999) The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res 31, 569–573.
Hollman PCH, de Vries JHM, van Leewen SD, Mengelers MJB, and Katan MB (1995) Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 62, 1276–1282.
Hong JT, Yen JH, Wang L, Lo YH, Chen ZT, and Liu MJ (2009) Regulation of heme oxygenase-1 expression and MAPK pathways in response to kaempferol and rhamnocitrin in PC12 cells. Toxicol and Appl Pharmacol 237, 59–68.
Hou Y, Aboukhatwa MA, Lei DL, Manaye K, Khan I, and Luo Y (2009) Anti depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice. Neuropharmacol 58, 911–920.
Hsiang CY, Wu SL, and Ho JY (2005) Morin inhibits 12-O-tetra decanoylphorbol-13-acetate-induced hepatocellular transformation via activator protein 1 signalling pathway and cell cycle progression. Biochem Pharmacol 69, 1603–1611.
Hwang MK, Song RY, Kang NJ, Lee KW, and Lee HJ (2009) Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-α-induced upregulation of matrix metalloproteinase-9: Its direct inhibition by quercetin. Intl J Biochem Cell Biol 41, 1592–1600.
Jorge AP, Horst H, de Sousa E, Pizzolatti MG, and Silva FR (2004) Insulinomimetic effects of kaempferitrin on glycaemia and on 14C-glucose uptake in rat soleus muscle. Chem Biol Interact 149(2–3), 89–96.
Jung SK, Lee KW, Kim HY, Oh MH, Byun S, Lim SH, Heo YS, Kang NJ, Bode AM, Dong Z, and Lee HJ (2010) Myricetin suppresses UVB-induced wrinkle formation and MMP-9 expression by inhibiting Raf. Biochem Pharmol 79, 1455–1461.
Justesen U, Knuthsen P, and Torben L (1997) Determination of plant polyphenols in Danish foodstuffs by HPLC-UV and LC-MS detection. Cancer Lett 114, 165–167.
Kaliora AC, Dedoussis GVZ, and Schmidt H (2006) Dietary antioxidants in preventing atherogenesis. Atheroscler 187, 1–17.
Kim YJ, Bae YC, Suh KT, and Jung JS (2006) Quercetin, a flavonoids, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem pharmacol 72, 1268–1278.
Komori A, Yatsunami J, Okabe S, Abe S, Hara K, Suganuma M, Kim SJ, and Fujiki H (1993) Anticarcinogenic activity of green tea polyphenols. Jpn J Clin Oncol 23, 186–90.
Kühnau J (1976) The flavonoids, a class of semi-essential food components: Their role in human nutrition. World Rev Nutr Diet 24, 117–191.
Kuhnle G, Spencer JPE, Schroeter H, Shenoy B, Debnam ES, Srai SKS, Rice Evans C, and Hahn U (2000) Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochem Biophys Res Commun 277, 507–512.
Kumamoto T, Fujii M, and Hou DX (2009) Myricetin directly targets JAK1 to Inhibit cell transformation. Cancer Lett 275, 17–26.
Kumar VK, Vennila S, and Nalini N (2010) Inhibitory effect of morin on DMH-induced biochemical changes and aberrant crypt foci formation in experimental colon carcinogenesis. Environ Toxicol Pharmacol 29, 50–57.
Lansky EP and Newman RA (2007) Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 109, 177–206.
Larocca LM, Ghjstacchini M, Maggiano N, Ranelletti FO, Piantelli M, Alcini E, and Capelli A (1994) Growthinhibitory effect of quercetin and presence of type II estrogen binding sites in primary human transitional cell carcinomas. J Urol 152, 1029–1033.
Lea MA, Xiao Q, Sadhukhan AK, Cottle S, Wang ZY, and Yang CS (1993) Inhibitory effects of tea extract and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. Cancer Lett 68, 231–236.
Lee-Hilz YY, Stolaki M, van Berkel WJH, Aarts JMMJG, and Rietjens IMCM (2008) Activation of EpRE-mediated gene transcription by quercetin glucuronides depends on their deconjugation. Food Chem Toxicol 46, 2128–2134.
Lee JD, Huh JE, Jeon GS, Yang HR, Woo HS, Choi DY, and Park DS (2009a) Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Intl Immunopharmacol 9, 268–276.
Lee MJ, Rao YK, Chen K, Lee YC, and Tzeng YM (2009b) Effect of flavonol glycosides from Cinnamomum osmophloeum leaves on adiponectin secretion and phosphorylation of insulin receptor-β in 3T3-L1 adipocytes. J Ethnopharmacol 126, 79–85.
Leenen R, Roodenburg AJC, Tijburg LBM, and Wiseman SA (2000) Eur J Clin Nutr 54, 87–92.
Lee SS, Lin HC, and Chen CK (2008) Acylated flavonol monorhamnosides, α-glucosidase inhibitors, from Machilus philippinensis. Phytochem 69, 2347–2353.
Leung HW, Lin CJ, Hour MJ, Yang WH, Wang MY, and Lee HZ (2007) Kaempferol induces apoptosis in human lung non-small carcinoma cells accompanied by an induction of antioxidant enzymes. Food Chem Toxicol 45, 2005–2013.
Li W, Du B, Wang T, Wang S, and Zhang J (2009) Kaempferol induces apoptosis in human HCT116 colon cancer cells via the ataxia-telangiectasia mutated-p53 pathway with the involvement of p53 upregulated modulator of apoptosis. Chem-Biol Interactions 177, 121–127.
López-Lázaro M, Willmore E, and Caroline AA (2010) The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells. Mutation Res 696, 41–47.
Maher P, Salgado KF, Zivin JA, and Lapchak PA (2007) A novel approach to screening for new neuroprotective compounds for the treatment of stroke. Brain Res 1173, 117–125.
Manach C, Morand C, Crespy V, Demigné C, Régérat F, and Rémésy C (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426, 331–336.
Manach C, Regerat F, Texier O, Agullo G, Demigne C, and Remesy C (1996) Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids. Nutr Res 16, 517–544.
Mariani C, Braca A, Vitalini S, De Tommasi N, Visioli F, and Fico G (2008) Flavonoid characterization and in vitro antioxidant activity of Aconitumanthora L. (Ranunculaceae). Phytochem 69, 1220–1226.
Matsuda H, Wang T, Managi H, and Yoshikawa M (2003) Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. BIOORGAN MED CHEM 11, 5317–5323.
McAnlis GT, McEneny J, Pearce J, and Young IS (1998) Quercetin levels in plasma and resistance to oxidation after fried onion breakfast (abstract). Proc Nutr Soc 57, 4A.
McCarty MF (2008) Scavenging of peroxynitrite-derived radicals by flavonoids may support endothelial NO synthase activity, contributing to the vascular protection associated with high fruit and vegetable intakes. Medical Hypotheses 70, 170–181.
McDonald IA, Mader JA, and Bussard RG (1983) The role of rutin and quercitrin in stimulating flavonol glycosidase activity by cultured cell-free microbial preparations of human faeces and saliva. Mutat Res 122, 95–102.
Meotti FC, Missau FC, Fereira J, Pizzolatti MG, Mizuzaki C, Nogueira CW, and Santos ARS (2006) Anti-allodynic property of flavonoid myricitrin in models of persistent inflammatory and neuropathic pain in mice. Biochem Pharmacol 72, 1707–1713.
Middleton EJR, Kandaswami C, and Theoharides TC (2000) The effect of plant flavonoids on mammalian cells. Implications for inflammation, heart disease and cancer. Pharmacol Rev 52, 673–751.
Mojca Š, Petra K, Majda H, Andreja RH, Marjana S, and Željko K (2005) Phenols, proanthocyanidins, flavones and flavonols in some plant materials and their antioxidant activities. Food Chem 89, 191–198.
Morikawa K, Nonaka M, Narahara M, Torii I, Kawaguchi K, Yoshikawa T, Kumazawa Y, and Morikawa S (2003) Inhibitory effect of quercetin on carrageenan-induced inflammation in rats. Life Sci 74, 709–721.
Moskaug JO, Carlsen H, Myhrstad M, and Blomhoff R (2004) Molecular imaging of the biological effects of quercetin and quercetin-rich foods. MECH AGEING DEV 125, 315–324.
Muthukumaran S, Sudheer AR, Menon VP, and Nalini N (2008) Protective effect of quercetin on nicotine-induced prooxidant and antioxidant imbalance and DNA damage in Wistar rats. Toxicol 243, 207–215.
Nassiri-Asl M, Shariati-Rad S, and Zamansoltani F (2008) Anticonvulsive effects of intracerebroventricular administration of rutin in rats. PROG NEUROPSYCHOPH 32, 989–993.
Natsume Y, Ito S, Satsu H, and Shimizu M (2009) Protective effect of quercetin on ER stress caused by calcium dynamics dysregulation in intestinal epithelial cells. Toxicol 258, 164–175.
Navarro-Núñez L, Lozano ML, Martínez C, Vicente V, and Rivera J (2010) Effect of quercetin on platelet spreading on collagen and fibrinogen and on multiple platelet kinases. Fitoterapia 81, 75–80.
Niering P, Michels G, Wätjen W, Ohler S, Steffan B, Choovolou Y, Kampkötter A, Proksch P, and Kahl R (2005) Protective and detrimental effects of kaempferol in rat H4IIE cells: Implication of oxidative stress and apoptosis. Toxicol Appl Pharmacol 209, 114–122.
Nishi J, Ogura R, Sugiyama M, Hidaka T, and Kohno M (1991) Involvement of active oxygen in lipid peroxide radical reaction of epidermal homogenate following ultraviolet light exposure. J Invest Dermatol 97, 115–119.
Oliveira EJ and Watson DG (2000) In vitro glucuronidation of kaempferol and quercetin by human UGT-1A9 microsomes. FEBS Lett 471, 1–6.
Olthof MR, Hollman PCH, Vree TB, and Katan MB (2000) Bioavailabilities of quercetin-3 glucoside and quercetin-4′-glucoside do not differ in humans. J Nutr 130, 1200–1203.
Park CH, Chang JY, Hahm ER, Park S, Kim HK, and Yang CH (2005) Quercetin, a potent inhibitor against β-catenin/Tcfr signaling in SW480 colon cancer cells. Biochem Biophys Res Commun 328, 227–234.
Pelzer LE, Guardia T, Juarez AO, and Guerreiro E (1998) Acute and chronic antiinflammatory effects of plant flavonoids. IL Farrnaco 53, 421–424.
Pietta PG (2000) Flavonoids as antioxidants. J Nat Prod 63, 1035–104.
Regasini LO, Vellosa JC, Silva DH, Furlan M, de Oliveira OM, Khalil NM, Brunetti IL, Young MC, Barreiro EJ, and Bolzani VS (2008) Flavonols from pterogyne nitens and their evaluation as myeloperoxidase inhibitors. Phytochem 69, 1739–1744.
Rimm EB, Katan MB, Ascherio A, Stampfer MJ, and Willett WC (1996) Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 125, 384–389.
Roghani M, Baluchnejadmojarad T, Vaez-Mahdavi MR, and Roghani-Dehkordi F (2005) Mechanisms underlying quercetin-induced vasorelaxation in aorta of subchronic diabetic rats: an in vitro study. Vas Pharmacol 42, 31–35.
Rotelli AE, Guardia T, Juárez AO, de la Rochal NE, and Pelzer LE (2003) Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res 48, 601–606.
Ruggeri ZM and Mendolicchio GL (2007) Adhesion mechanisms in platelet function. Circ Res 100, 1673–1685.
Shang XY, Wang YH, Li C, ZhangCZ, Yang YC, and Shi JG (2006) Acetylated flavonol diglucosides from Meconopsis quintuplinervia. Phytochem 67, 511–515.
Sivaramakrishnan V and Devaraj SN (2010) Morin fosters apoptosis in experimental hepatocellular carcinogenesis model. Chem-Biol Interactions 183, 284–292.
Sivaramakrishnan V and Devaraj SN (2009) Morin regulates the expression of NFB p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chem-Biol Interactions 180, 353–359.
Smith GJ, Thomsen SJ, Markham KR, Andary C, and Cardon D (2000) The photostabilities of naturally occurring 5-hydroxyflavones, flavonols, their glycosides and their aluminium complexes. J Photochem Photobiol A 136, 87–91.
Soobrattee MA, Neergheen VS, Luximon-Ramma A, Aruoma OI, and Bahorun T (2005) Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutat Res 579, 2000–2013.
Stoclet JC, Chataigneau T, Ndiaye M, Oak MH, El Bedoui J, Chataigneau M, Schini, and Kerth VB. (2004) Vascular protection by dietary polyphenols. Eur J Pharmacol 500, 299–313.
Takahama U (1985) Inhibition of lipoxygenase-dependent lipid peroxidation by quercetin: Mechanism of antioxidative function. Phytochem 24, 1443–1446.
Walle T, Otake Y, Walle UK, and Wilson FA (2000) Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. J Nutr 130, 2658–2661.
Wärngård L, Flodström S, Ljungquist S, and Ahlborg UG (1987) Interaction between quercetin, TPA and DTT in the V79 metabolic cooperation assay. Carcinogenesis 8, 1201–1205.
Watson SP, Auger JM, McCarty OJ, and Pearce AC (2005) GPVI and integrin alpha IIb Beta 3 signaling in platelets. J Thromb Haemost 3, 1752–1762.
Weckerle B, Michel K, Balázs B, Schreier P, and Tóth G (2001) Quercetin 3, 3′, 4′-tri O-β-D-glucopyranosides from leaves of Eruca sativa (Mill.). Phytochem 57, 547–551.
Winter J, Moore LH, Dowell VR JR, and Bokkenheuser VD (1989) C-ring cleavage of flavonoids by human intestinal bacteria. Appl Env Microbiol 55, 1203–1208.
Woodman OL and Chan ECH (2004) Vascular and anti-oxidant actions of flavonols and flavones. Clin Exp Pharmacol Physiol 31, 786–790.
Xu YM, Smith JA, Lannigan DA, and Hecht SM (2006) Three acetylated flavonol glycosides from Forsteronia refracta that specifically inhibit p90 RSK. Bioorgan Med Chem 14, 3974–3977.
Yang JH, Kondratyuk TP, Marler LE, Qiu X, Choi Y, Cao H, Yu R, Sturdy M, Pegan S, Liu Y, Wang LQ, Mesecar AD, Van Breemen RB, Pezzuto JM, Fong HH, Chen YG, and Zhang HJ. (2010) Isolation and evaluation of kaempferol glycosides from the fern Neocheiropteris palmatopedata. Phytochem 71, 641–647.
Yang RZ, Wei XL, Gao FF, Wang LS, Zhang HJ, Xu YJ, Li CH, Ge YX, Zhang JJ, and Zhang J (2009) Simultaneous analysis of anthocyanins and flavonols in petals of lotus (Nelumbo) cultivars by high performance liquid chromatography-photodiode array detection/electrospray ionization mass spectrometry. J Chromatogr A 1216, 106–112.
Yao LH, Jiang YM, Shi J, Tomas-Barberan FA, Datta N, Singanusong R, and Chen SS (2004) Flavonoids in food and their helath benefits. Plant Food Hum Nutr 59, 113–122.
Ye B, Aponte M, Dai Y, Li L, Ho MC, Vitonis A, Edwards D, Huang TN, and Cramer DW (2007) Ginkgo biloba and ovarian cancer prevention: Epidemiological and biological evidence. Cancer Lett 251, 43–52.
Yen FL, Wu TH, Lin LT, Cham TM, and Lin CC (2008) Concordance between antioxidant activities and flavonol contents in different extracts and fractions of Cuscuta chinensis. Food Chem 108, 455–462.
Yilmazer M, Stevens JF, and Buhler DR (2001) In vitro glucuronidation of xanthohumol, a flavonoid in hop and beer, by rat and human liver microsomes. FEBS Lett 491, 252–256.
Zhang Q, Xin-Huai Z, and Zhu-Jun W (2009) Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol in Vitro 23, 797–807.
Zhang Q, Zhao XH, and Wang ZJ (2008) Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem Toxicol 46, 2042–2053.
Zhu JTT, Choi RCY, Xie HQ, Zheng KYZ, Guo AJY, Bi CWC, Lau DTW, Li J, Dong TTX, Lau BWC, Chen JJ, and Tsim KWK (2009) Hibifolin, a flavonol glycoside, prevents β-amyloid-induced neurotoxicity in cultured cortical neurons. Neurosci Lett 461, 172–176.
About this article
Cite this article
Survay, N.S., Upadhyaya, C.P., Kumar, B. et al. New genera of flavonols and flavonol derivatives as therapeutic molecules. J. Korean Soc. Appl. Biol. Chem. 54, 1–18 (2011). https://doi.org/10.3839/jksabc.2011.001